LEPU ScienTech Medical Technology (HKG:2291) resumed trading on the Hong Kong bourse Wednesday after halting trading of its shares Tuesday following price share fluctuations.
The medical device company attributed the share movement to investor recognition of its "continuous" results and performance growth, as well as the restoration of its value, according to a same-day filing with the Hong Kong bourse.
LEPU ScienTech forecast a 30% rise in its sales target for its occluder product and 200 million yuan sales for its transcatheter aortic valve replacement product, the filing said.
LEPU ScienTech suspended trading Tuesday morning at 10:57 a.m. and closed at HK$23.55. It resumed trading Wednesday morning, opening 8% higher at HK$25.50.
Shares plunged 14% during afternoon trading on Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.